For example, Jiang et al. showed that high CD19+ tumor-infiltrating B cells correlated with improved overall survival and enhanced response to platinum-based chemotherapy, in part through their antigen-presenting role in priming CD4+ T cells [40]. This evidence concerns the gene CD4 and neoplasm.